Child growth failure still drives a massive share of under-5 death and disability
Child growth failure remains one of the most consequential pediatric nutrition problems in global health, and the latest Global Burden of Disease analysis places its impact in stark numerical terms. In 2023, child growth failure—defined across stunting, wasting, and underweight—was associated with 79.4 million disability-adjusted life-years lost and 880,000 deaths in children younger than 5 years. Those figures translate into 17.9% of all under-5 DALYs and 18.8% of all under-5 deaths worldwide.
The burden is not confined to one phenotype of poor growth. The analysis treats child growth failure as a continuum, capturing mild, moderate, and severe forms rather than limiting attention to the most extreme cases. That design matters clinically because children do not move neatly between categorical labels; growth deficits accumulate, overlap, and interact with infection risk long before a child reaches the threshold for severe malnutrition. In practical terms, the excess mortality linked to growth failure is being generated across a wide spectrum of anthropometric compromise.
Underweight carried the largest share of the global burden
Among the individual indicators, underweight accounted for the largest burden. In 2023, underweight was associated with 52.2 million DALYs and 573,000 deaths in children younger than 5 years. By comparison, stunting accounted for 33.0 million DALYs and 373,000 deaths, while wasting was associated with 39.2 million DALYs and 428,000 deaths.
The pattern is clinically revealing. Underweight is not a biologically isolated state; it often captures the combined effects of chronic undernutrition, acute weight loss, repeated infection, and delayed recovery from illness. Because it can reflect both long-standing and recent nutritional stress, it may function as a broad marker of physiologic vulnerability rather than a narrow anthropometric endpoint. In that sense, the larger burden associated with underweight is consistent with the way pediatric malnutrition presents at the bedside: children rarely arrive with a single, neatly separated deficit.
One sentence explains the entire burden signal: the broadest growth deficit carried the heaviest mortality load.
The analysis linked growth failure to infection-related deaths through multiple data streams
The study estimated the risk of incidence and mortality for diarrhoea, lower respiratory tract infections, malaria, and measles among children with Z scores below -1, using longitudinal cohort data modeled in a meta-regression framework. Fatal outcomes were then estimated with vital registration, verbal autopsy, and case-fatality data, while non-fatal outcomes drew on surveys, health-care utilization data, and case reporting systems. Population-level distributions of height-for-age, weight-for-age, and weight-for-height Z scores were reconstructed for 2000 through 2023 using surveys, published literature, and individual-level studies.
This approach is important because the mortality signal is not simply an abstract statistical construct. Poor growth weakens immune function, reduces physiologic reserve, and increases susceptibility to common infections that are already major killers in early childhood. Diarrhoeal disease and pneumonia are particularly relevant because they both worsen nutritional status and are worsened by it, creating a reinforcing cycle of illness, poor intake, malabsorption, and catabolism. Malaria and measles add another layer of vulnerability in settings where infectious exposures and nutritional deficits intersect.
The investigators also used continuous distributions for exposure and relative risk, allowing direct estimation of attributable fractions across mild, moderate, and severe growth failure. This is a more realistic representation of pediatric risk than a simple yes-or-no threshold, because a child with modest deficits can still contribute meaningfully to population burden when prevalence is high.
The burden remained high despite global attention to child nutrition
The central message from the 2023 estimates is blunt. Child growth failure still accounts for a large and preventable share of death and disability in the world’s youngest children, despite sustained policy attention and repeated intervention efforts over many years.
That persistence points to the limits of programs that target only one aspect of malnutrition or focus too narrowly on severe acute wasting. A child with stunting may also be underweight; a child with wasting may also be stunted; and underweight may capture a mixed clinical state that signals elevated risk even when a single anthropometric indicator looks less extreme. Health systems that only identify the most obvious cases will miss a large segment of children already on the path toward infection, hospitalization, and death.
The geography-specific, sex-specific, age-specific, and year-specific estimates strengthen the practical relevance of the analysis. Growth failure does not distribute evenly across populations, and the burden varies by context, access to food, infection exposure, sanitation, maternal health, and the reach of primary care. Those forces shape whether a child with poor growth can be identified early enough to benefit from treatment, supplementation, infection control, and follow-up.
Child survival policy has to address all growth indicators, not one marker alone
The findings support a broader prevention strategy that treats stunting, wasting, and underweight as related but not interchangeable risks. Programs centered only on one indicator may underestimate the total number of children at risk and miss opportunities to interrupt the infection-malnutrition cycle before death or lasting disability occurs.
At the clinical level, the implications are straightforward. Screening must look across the full growth spectrum, and prevention cannot rely on a single metric or a single intervention package. The biologic logic is cumulative: inadequate intake, recurrent infection, immune dysfunction, and slowed recovery combine to create a durable vulnerability state in early childhood.
The analysis leaves one unavoidable question in practice: how quickly can health systems translate these burden estimates into earlier case finding and broader coverage of effective nutrition and infection-prevention programs in the settings where under-5 mortality remains highest?